secwatch.observer — SEC 8-K summary
======================================

Issuer:     Xenetic Biosciences, Inc. (XBIO)
CIK:        0001534525
Form:       8-K
Filed at:   2024-12-13T23:59:59+00:00
Accession:  0001683168-24-008712
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Xenetic Biosciences reports results of 2024 annual meeting; all proposals pass
------------------------------------------------------------------------------

- All six director nominees elected; for votes ranged from 458,022 to 486,395; broker non-votes 391,780.
- Ratification of Marcum LLP as auditor approved: 878,207 for, 15,137 against, 3,419 abstain.
- Advisory say-on-pay compensation approved: 462,285 for, 40,600 against, 2,098 abstain.
- Say-on-frequency set to every 1 year: 470,918 for 1 year; 3,600 for 2 years; 3,631 for 3 years.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1534525/000168316824008712/0001683168-24-008712-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1534525/000168316824008712/xenetic_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-24-008712

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer